Latest Tenet Healthcare Corp (THC) Headlines SmarTrend

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Tenet Healthcare Corp (THC) Headlines

SmarTrend Watching for Potential Rebound in Shares of Tenet Healthcare After 1.09% Loss
Comtex SmarTrend(R) - Fri Mar 14, 5:07PM CDT
Tenet Healthcare (NYSE:THC) traded in a range yesterday that spanned from a low of $39.10 to a high of $40.76. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $39.87 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

HealthCare Stocks Technical Notes: Community Health Systems, HCA Holdings, Tenet Healthcare, and Universal Health Services
PR Newswire - Wed Mar 12, 11:46AM CDT
On Tuesday, March 11, 2014, the NASDAQ Composite ended at 4,307.19, down 0.63%, the Dow Jones Industrial Average fell 0.41% to 16,351.25, and the S&P 500 closed at 1,867.63, down 0.51%. The losses were broad based as nine out of ten sectors edged lower. The S&P 500 Health Care Sector Index finished the day at 687.97, down 0.26%, while the same has advanced 3.29% in the last one month. Investor-Edge.com has initiated coverage on the following equities: Community Health Systems Inc. (NYSE: CYH), HCA Holdings Inc. (NYSE: HCA), Tenet Healthcare Corporation (NYSE: THC), and Universal Health Services Inc. (NYSE: UHS). Free research on these four companies can be accessed at:

The HCI Group Names Chief Medical Information Officer and Senior Vice President of Delivery Operations to lead New Services Lines
PRWeb - Tue Mar 11, 8:07AM CDT
The HCI Group, a leading provider of health care information technology strategy and enterprise consulting services to health care organizations, has named Dr. William Bria as its chief medical information officer and Robert Steele, formerly senior director of applied clinical informatics at the corporate level for Tenet Healthcare, Dallas, Texas, as its senior vice president of delivery operations.

Tenet Announces Completion of Private Offering of Senior Notes
Business Wire - Mon Mar 10, 1:00PM CDT
Tenet Healthcare Corporation (NYSE: THC) announced the successful completion of its previously announced private offering of $600 million aggregate principal amount of 5.00% senior notes due 2019.

Tenet Healthcare Earnings In Retrospect: Down 12.5% in the Last 14 Days (THC)
Comtex SmarTrend(R) - Mon Mar 10, 8:37AM CDT
Two weeks ago on February 24th, 2014 Tenet Healthcare (NYSE:THC) reported earnings and analysts, on average, expected earnings of $0.32 on sales of $3.9 billion. Tenet Healthcare actually reported earnings of $0.43 per share on sales of $3.9 billion, beating EPS estimates by $0.11 and missing revenue estimates by $2.4 million. Shares of Tenet Healthcare have slipped from $48.33 to $42.31, representing a loss of 12.5%, since the company reported earnings 14 days ago.

Tenet, Yale New Haven Collaborate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 1:30PM CST
Tenet Healthcare Corporation is set to establish its foothold in Connecticut through its latest partnership with Yale New Haven Health System

Tenet to Present at the Barclays Global Healthcare Conference on March 11
Business Wire - Fri Mar 07, 8:01AM CST
Tenet Healthcare Corporation (NYSE:THC) will participate in the 2014 Barclays Global Healthcare Conference in Miami on Tuesday, March 11, 2014. Trevor Fetter, president and chief executive officer of Tenet Healthcare, is scheduled to present at the conference at approximately 9:00 a.m. EDT.

Tenet Prices Senior Notes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 12:20PM CST
Tenet Healthcare Corporation has recently announced that it is issuing 5-year senior unsecured notes worth $600 million

Fitch Rates Tenet Healthcare Corp.'s Senior Unsecured Notes 'B-/RR5'
Business Wire - Thu Mar 06, 11:24AM CST
Fitch Ratings has assigned a 'B-/RR5' rating to Tenet Healthcare Corp.'s (Tenet) $600 million 5% senior unsecured notes due 2019. Proceeds will be used to refinance outstanding debt and for general corporate purposes. The Rating Outlook is Stable. A full list of ratings follows at the end of this press release. The ratings apply to approximately $10.9 billion of debt as of Dec. 31, 2013.

Tenet Healthcare prices private offering of USD600m senior notes
M2 - Thu Mar 06, 7:07AM CST
Healthcare company Tenet Healthcare (NYSE:THC) said on Wednesday that it has priced its private offering of USD600m aggregate principal amount of senior notes maturing in 2019.

Yale New Haven Health System and Tenet Healthcare Announce Partnership
Business Wire - Thu Mar 06, 6:00AM CST
Yale New Haven Health System and Tenet Healthcare Corporation (NYSE:THC) have formed a partnership to create a comprehensive health care delivery network in Connecticut, with the intention to expand into the greater Northeast region.

HCA to Issue Senior Notes, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 3:58PM CST
Shares of HCA Holdings, Inc. moved down 1.2% to $51.06 on Mar 4, 2014 after the company decided to issue senior secured notes worth $3 billion.

Tenet Announces Pricing of Private Offering of Senior Notes
Business Wire - Wed Mar 05, 3:34PM CST
Tenet Healthcare Corporation (NYSE: THC) established today the pricing of the previously announced private offering of senior notes maturing in 2019 (the "notes"). A total of $600 million aggregate principal amount of notes, which will bear interest at a rate of 5.00% per annum, will be issued.

Tenet Announces Private Offering of Senior Notes
Business Wire - Wed Mar 05, 7:54AM CST
Tenet Healthcare Corporation (NYSE: THC) is offering to sell $400 million aggregate principal amount of senior notes through a private placement. The proceeds from the offering will be used for general corporate purposes, including the repayment of indebtedness and drawings under Tenet's senior secured revolving credit facility and related transaction fees and expenses.

Is This Hospital Stock Undervalued?
Bob Chandler, The Motley Fool - Motley Fool - Mon Mar 03, 5:30PM CST
Tenet Healthcare Corp. shares took a tumble recently, plunging more than 8% in one day after guidance missed analyst estimates. But are things at the hospital operator as bad as the share price collapse suggests? There is evidence that the stock...

The Key Obamacare Benefit Most People Ignore
David Williamson and Dan Caplinger, The Motley Fool - Motley Fool - Sun Mar 02, 9:15AM CST
The Patient Protection and Affordable Care Act, better known as Obamacare, is leading to millions of people getting insurance coverage who previously didn't have it. Many have pointed to the profit potential that insurance companies WellPoint , ...

Tenet Arm, University Health Pen Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 3:55PM CST
Tenet Healthcare subsidiary Conifer Health Solutions has inked a deal with University Health System.

University Health System Selects Conifer Health Solutions to Deliver Revenue Cycle Management Services
Business Wire - Wed Feb 26, 1:35PM CST
Conifer Health Solutions has reached an agreement with University Health System to provide revenue cycle management services to 452-bed University Health Shreveport and 247-bed University Health Conway.

Company news for February 26, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 9:06AM CST
Companies in the News are: ZU,TSCO,RP,THC

Weakness Seen in Tenet Healthcare (THC): Stock Tumbles 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 7:56AM CST
Tenet Healthcare Corp. (THC) saw a big move last session. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $44.07 to $48.33 in the past one-month time frame.

Tenet Healthcare Corp. (THC) Stock Research Links

THC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 295

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 143

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 132

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 143

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 185

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 70

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading

Top 5 Most Recently Viewed Articles

WTW Welcomes Dale Porfilio as Director for Business Development

Updated Category News Views 138

WTW Appoints New Leader for Business Development In a significant move to enhance its operations, WTW (NASDAQ: WTW) has announced the appointment of Dale Porfilio as Senior Director and Head of Personal and Commercial Lines Business Development within its Insurance Consulting & Technology (ICT) segment. A Seasoned Professional Joins WTW Porfilio brings a wealth of...

Continue Reading
Jorgen Vig Knudstorp's Bold Stock Purchase at Starbucks

Updated Category News Views 74

Jorgen Vig Knudstorp Invests in Starbucks, Showing Strong Confidence Recently, Jorgen Vig Knudstorp, a director at Starbucks Corp (NASDAQ:SBUX), made a significant move by buying shares of the company. This act signals a firm vote of confidence in the future of the beloved coffee chain. When insiders make such investments, it often grabs the attention of other investors...

Continue Reading
Understanding Inventiva's Latest Half-Year Report and Future Plans

Updated Category News Views 65

Inventiva Files its 2024 Half-Year Report Inventiva, a prominent clinical-stage biopharmaceutical company, is making significant strides in the healthcare sector. Focused on developing oral therapies for metabolic dysfunction-associated steatohepatitis, commonly known as MASH/NASH, the company recently announced its filing of the 2024 Half-Year Report for the period...

Continue Reading
Analyzing Organon's Upcoming Earnings Announcement and Insights

Updated Category News Views 177

Anticipation Surrounding Organon's Earnings Report Organon (OGN) is on the verge of revealing its quarterly earnings report, a moment eagerly awaited by investors. As preparations finalize for this significant announcement, understanding the forecasted outcomes can guide investor decisions moving forward. Expected Earnings Figures Forecast estimates suggest that Organon...

Continue Reading
Miami Real Estate Trends: A Surge in Older Condo Sales

Updated Category News Views 180

Understanding the Miami-Dade Real Estate Market Miami-Dade County's real estate landscape is shifting, with older condominiums experiencing quicker sales than their newer counterparts. This trend indicates a solid demand for older condos, highlighting their appeal in a market where affordable housing options continue to thrive. Statistical data reveal that older...

Continue Reading